top of page
Lecture 28: Thrombotic Microangiopathies/TTP
Mari Thomas MD, PhD
Presentation Date:
May 7, 2026
Disclosures:
Research Support: BHF, Thrombosis UK, Anthos
Advisory Boards (In past 5 years) Sanofi, Bayer, Anthos
Learning Objectives
> What is a Thrombotic Microangiopathy (TMA)?
> Thrombotic Thrombocytopenic Purpura: TTP
> Pathophysiology
> Diagnosis
> Therapies
> Long term effects and monitoring
> Congenital TTP
> Complement mediated HUS
> Other TMA
bottom of page
.jpg)

